Neuronal acetylcholine receptor α9-subunit: A possible central nervous system autoantigen

Medical Hypotheses

Volumn 67, Issue 3, 2006, Pages 561-565

  Tüzün, Erdem ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA 1 SUBUNIT; ACETYLCHOLINE RECEPTOR ALPHA 9 SUBUNIT; AUTOANTIGEN; CHOLINERGIC RECEPTOR ANTIBODY; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; IMMUNOREACTIVITY; MOUSE; MUSCLE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; AUTOANTIGENS; CENTRAL NERVOUS SYSTEM; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; NEURONS; PROTEIN SUBUNITS; RECEPTORS, CHOLINERGIC;

EID: 33745272256     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.03.012     Document Type: Article

References (24)

1. Christadoss P., Poussin M., and Deng C. Animal models of myasthenia gravis. Clin Immunol 94 2 (2000) 75-87
2. Stepansky R., and Zeitlhofer J. Myasthenia gravis and sleep. Wien Klin Wochenschr 113 7-8 (2001) 285-287
3. Watanabe S., Shimazu K., Tamura N., Yamamoto T., and Hamaguchi K. Central acetylcholine receptor function in patients with myasthenia gravis. Rinsho Shinkeigaku 31 2 (1991) 170-174
4. Fontana A., Fulpius B.W., and Cuenoud S. Antibodies against nicotine-like acetylcholine receptors of central nervous system and muscles in epileptics with IgA deficiency. Schweiz Med Wschr 108 34 (1978) 1307-1310
5. Keesey J.C. Does myasthenia gravis affect the brain?. J Neurol Sci 170 2 (1999) 77-89
6. Antoine J.C., Honnorat J., Anterion C.T., Aguera M., Absi L., Fournel P., et al. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Neurosurg Psychiatry 58 6 (1995) 706-710
7. Heilbronn E., Haggblad J., and Kubat B. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro. Ann NY Acad Sci 377 (1981) 198-207
8. Gelman I.H., Tombler E., and Vargas Jr. J. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis. Histochem J 32 1 (2000) 13-26
9. Weidenfeld J., Bodoff M., Saphier D., and Brenner T. Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 50 2 (1989) 132-138
10. Fabian-Fine R., Skehel P., Errington M.L., Davies H.A., Sher E., Stewart M.G., et al. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21 20 (2001) 7993-8003
11. Barrantes G.E., Rogers A.T., Lindstrom J., and Wonnacott S. Alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha 7 subunits and up-regulation by chronic nicotine treatment. Brain Res 672 1-2 (1995) 228-236
12. Britto L.R., Hamassaki-Britto D.E., Ferro E.S., Keyser K.T., Karten H.J., and Lindstrom J.M. Neurons of the chick brain and retina expressing both alpha-bungarotoxin-sensitive and alpha-bungarotoxin-insensitive nicotinic acetylcholine receptors: an immunohistochemical analysis. Brain Res 590 1-2 (1992) 193-200
13. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., and Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79 4 (1994) 705-715
14. Lips K.S., Pfeil U., and Kummer W. Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons. Neuroscience 115 1 (2002) 1-5
15. Drescher D.G., Ramakrishnan N.A., Drescher M.J., Chun W., Wang X., Myers S.F., et al. Cloning and characterization of alpha9 subunits of the nicotinic acetylcholine receptor expressed by saccular hair cells of the rainbow trout (Oncorhynchus mykiss). Neuroscience 127 3 (2004) 737-752
16. Newman M.B., Kuo Y.P., Lukas R.J., Sanberg P.R., Douglas Shytle R., McGrogan M.P., et al. Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons. Brain Res Dev Brain Res 139 1 (2002) 73-86
17. Colquhoun L.M., and Patrick J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv Pharmacol 39 (1997) 191-220
18. Johnson D.S., Martinez J., Elgoyhen A.B., Heinemann S.F., and McIntosh J.M. Alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors. Mol Pharmacol 48 2 (1995) 194-199
19. Nguyen V.T., Ndoye A., and Grando S.A. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 157 4 (2000) 1377-1391
20. Melms A., Chrestel S., Schalke B.C., Wekerle H., Mauron A., Ballivet M., et al. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. J Clin Invest 83 3 (1989) 785-790
21. Araga S., Galin F.S., Kishimoto M., Adachi A., and Blalock J.B. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors. J Immunol 157 1 (1996) 386-392
22. Tzartos S.J., Sophianos D., and Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. J Immunol 134 4 (1985) 2343-2349
23. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 6835 (2001) 269-276
24. Lennon V.A., Ermilov L.G., Szurszewski J.H., and Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111 6 (2003) 907-913